Associations of proteins relevant to MAPK signaling pathway (p38MAPK-1,HIF-1 and HO-1) with coronary lesion characteristics and prognosis of peri-menopausal women

[1]  G. Dimitriadis,et al.  Serum levels of retinol-binding protein-4 are associated with the presence and severity of coronary artery disease , 2014, Cardiovascular Diabetology.

[2]  M. Iacoviello,et al.  A Novel Cardiac Bio-Marker: ST2: A Review , 2013, Molecules.

[3]  M. Irwin,et al.  N-Acetylcysteine and Allopurinol Confer Synergy in Attenuating Myocardial Ischemia Injury via Restoring HIF-1α/HO-1 Signaling in Diabetic Rats , 2013, PloS one.

[4]  Shah Ebrahim,et al.  European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) , 2012, International Journal of Behavioral Medicine.

[5]  D. Relman,et al.  Myocardial depressant effects of interleukin 6 in meningococcal sepsis are regulated by p38 mitogen-activated protein kinase* , 2011, Critical care medicine.

[6]  Y. Bao,et al.  Serum Levels of Adipocyte Fatty Acid-Binding Protein Are Associated with the Severity of Coronary Artery Disease in Chinese Women , 2011, PloS one.

[7]  K. Machida,et al.  Ethanol-induced HO-1 and NQO1 Are Differentially Regulated by HIF-1α and Nrf2 to Attenuate Inflammatory Cytokine Expression* , 2010, The Journal of Biological Chemistry.

[8]  L. Jonasson,et al.  Inflammation and cortisol response in coronary artery disease , 2009, Annals of medicine.

[9]  R. Lieberman,et al.  Hypoxia associated p38 Mitogen Activated Protein Kinase Mediated Androgen Receptor Activation and Increased Hif-1α Levels Contribute to emergence of an Aggressive Phenotype in Prostate Cancer , 2008, Oncogene.

[10]  Jin-qing Yuan,et al.  Drug-eluting stents for the treatment of ostial coronary lesions: comparison of sirolimus-eluting stent with paclitaxel-eluting stent , 2008, Coronary artery disease.

[11]  Richard T. Lee,et al.  The IL-33/ST2 pathway: therapeutic target and novel biomarker , 2008, Nature Reviews Drug Discovery.

[12]  D. Mikhailidis,et al.  Elevated heart rate and atherosclerosis: an overview of the pathogenetic mechanisms. , 2008, International journal of cardiology.

[13]  I. Chaudry,et al.  Mechanism of estrogen-mediated intestinal protection following trauma-hemorrhage: p38 MAPK-dependent upregulation of HO-1. , 2008, American journal of physiology. Regulatory, integrative and comparative physiology.

[14]  Zhang Guo-hong,et al.  Hypoxia-inducible factor-1&agr; induces the coronary collaterals for coronary artery disease , 2008 .

[15]  Y. Cha,et al.  Role of heme oxygenase-1 in vascular disease. , 2008, Current pharmaceutical design.

[16]  Simon Capewell,et al.  Coronary heart disease mortality among young adults in the U.S. from 1980 through 2002: concealed leveling of mortality rates. , 2007, Journal of the American College of Cardiology.

[17]  Shah Ebrahim,et al.  European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invit , 2007, European heart journal.

[18]  Shah Ebrahim,et al.  Fourth Joint Task Force of the European Society of Cardiology and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) , 2007 .

[19]  L. V. von Segesser,et al.  Heart HIF-1α and MAP Kinases During Hypoxia: Are They Associated In Vivo? , 2007 .

[20]  Richard T. Lee,et al.  IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system. , 2007, The Journal of clinical investigation.

[21]  Youming Li,et al.  Delayed increase of tyrosine hydroxylase expression in rat nigrostriatal system after traumatic brain injury , 2007, Brain Research.

[22]  Meijing Wang,et al.  17-beta-Estradiol decreases p38 MAPK-mediated myocardial inflammation and dysfunction following acute ischemia. , 2006, Journal of molecular and cellular cardiology.

[23]  P. Thistlethwaite,et al.  Hypoxia-inducible factor 1-alpha reduces infarction and attenuates progression of cardiac dysfunction after myocardial infarction in the mouse. , 2005, Journal of the American College of Cardiology.

[24]  I. Hedenfalk,et al.  ERK1/2 inhibition increases antiestrogen treatment efficacy by interfering with hypoxia-induced downregulation of ERα: a combination therapy potentially targeting hypoxic and dormant tumor cells , 2005, Oncogene.

[25]  Wei Fang Chen,et al.  Diosgenin Induces Hypoxia-Inducible Factor-1 Activation and Angiogenesis through Estrogen Receptor-Related Phosphatidylinositol 3-kinase/Akt and p38 Mitogen-Activated Protein Kinase Pathways in Osteoblasts , 2005, Molecular Pharmacology.

[26]  Jiang He,et al.  Major causes of death among men and women in China. , 2005, The New England journal of medicine.

[27]  I. Yasinska,et al.  Regulation of MAP kinase-dependent apoptotic pathway: implication of reactive oxygen and nitrogen species. , 2005, Archives of biochemistry and biophysics.

[28]  S. Cuzzocrea,et al.  Hyperglycemia in streptozotocin-induced diabetic rat increases infarct size associated with low levels of myocardial HO-1 during ischemia/reperfusion. , 2005, Diabetes.

[29]  W. Weimar,et al.  Intragraft heme oxygenase-1 and coronary artery disease after heart transplantation. , 2004, Transplant immunology.

[30]  J. Brunzell,et al.  Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk. , 2004, The Journal of clinical endocrinology and metabolism.

[31]  V. Regitz-Zagrosek.  Cardiovascular disease in postmenopausal women. , 2003, Climacteric : the journal of the International Menopause Society.

[32]  Simon C Watkins,et al.  Carbon monoxide induces cytoprotection in rat orthotopic lung transplantation via anti-inflammatory and anti-apoptotic effects. , 2003, The American journal of pathology.

[33]  L. Novotný,et al.  Inverse Relationship Between Serum Bilirubin and Atherosclerosis in Men: A Meta-Analysis of Published Studies , 2003, Experimental biology and medicine.

[34]  N. Weissman,et al.  Paclitaxel Coating Reduces In-Stent Intimal Hyperplasia in Human Coronary Arteries: A Serial Volumetric Intravascular Ultrasound Analysis From the ASian Paclitaxel-Eluting Stent Clinical Trial (ASPECT) , 2003, Circulation.

[35]  S. Devaraj,et al.  C-Reactive Protein Increases Plasminogen Activator Inhibitor-1 Expression and Activity in Human Aortic Endothelial Cells: Implications for the Metabolic Syndrome and Atherothrombosis , 2003, Circulation.

[36]  H. Haddad,et al.  The prevalence of cardiac risk factors in women 45 years of age or younger undergoing angiography for evaluation of undiagnosed chest pain. , 2002, The Canadian journal of cardiology.

[37]  W. Durante,et al.  Heme oxygenase-1-derived carbon monoxide is an autocrine inhibitor of vascular smooth muscle cell growth. , 2002, Blood.

[38]  S. Yusuf,et al.  Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. , 2001, Circulation.

[39]  J. Slingerland,et al.  Constitutive MEK/MAPK Activation Leads to p27Kip1Deregulation and Antiestrogen Resistance in Human Breast Cancer Cells* , 2001, The Journal of Biological Chemistry.

[40]  J. Kurebayashi,et al.  Hypoxia Reduces Hormone Responsiveness of Human Breast Cancer Cells , 2001, Japanese journal of cancer research : Gann.

[41]  D. Levy,et al.  Total serum bilirubin and risk of cardiovascular disease in the Framingham offspring study. , 2001, The American journal of cardiology.

[42]  A. Choi,et al.  Heme oxygenase: colors of defense against cellular stress. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[43]  M. Mayer,et al.  Association of serum bilirubin concentration with risk of coronary artery disease. , 2000, Clinical chemistry.

[44]  Hiroshi Yamamoto,et al.  The Receptor for Advanced Glycation End Products Is Induced by the Glycation Products Themselves and Tumor Necrosis Factor-α through Nuclear Factor-κB, and by 17β-Estradiol through Sp-1 in Human Vascular Endothelial Cells* , 2000, The Journal of Biological Chemistry.

[45]  L. Chen,et al.  Clinical factors and angiographic features associated with premature coronary artery disease. , 1995, Chest.

[46]  M. Beato,et al.  Steroid hormone receptors: interaction with deoxyribonucleic acid and transcription factors. , 1993, Endocrine reviews.

[47]  P. Toutouzas,et al.  Coronary collateral circulation in coronary artery disease and systemic hypertension. , 1991, The American journal of cardiology.

[48]  W. Kannel.  CHD risk factors: a Framingham study update. , 1990, Hospital practice.

[49]  G. Semenza,et al.  Complete loss of ischaemic preconditioning-induced cardioprotection in mice with partial deficiency of HIF-1 alpha. , 2008, Cardiovascular research.

[50]  Chunjiang Tan,et al.  Hypoxia-inducible factor-1alpha induces the coronary collaterals for coronary artery disease. , 2008, Coronary artery disease.

[51]  Y. Kan,et al.  Adeno-associated viral vector-delivered hypoxia-inducible gene expression in ischemic hearts. , 2007, Methods in molecular biology.

[52]  L. V. von Segesser,et al.  Heart HIF-1alpha and MAP kinases during hypoxia: are they associated in vivo? , 2007, Experimental biology and medicine.

[53]  J. Mckenney,et al.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.

[54]  W. Kannel,et al.  Risk stratification in hypertension: new insights from the Framingham Study. , 2000, American journal of hypertension.

[55]  H. Yamamoto,et al.  The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-alpha through nuclear factor-kappa B, and by 17beta-estradiol through Sp-1 in human vascular endothelial cells. , 2000, The Journal of biological chemistry.